Alzheon Appoints Former GlaxoSmithKline CEO Jean-Pierre Garnier As Chairman Of Board Of Directors

FRAMINGHAM, Mass.--(BUSINESS WIRE)--Alzheon, Inc., a clinical-stage biopharmaceutical company focused on brain health, memory and aging, announced today that Jean-Pierre Garnier, PhD, has been appointed Chairman of the Board of Directors of the company. Dr. Garnier brings world-class expertise and global perspective to help build Alzheon into a leading clinical-stage Alzheimer’s company.

Back to news